Search

Search Results
Results 281 - 290 of 302 for Short bowel syndrome
  • Actemra
    Drug - 5 Sep 2022
    Consumer Medicine Information (CMI) about Actemra intended for persons living in Australia.
  • Somac Injection
    Drug - 26 Aug 2022
    Consumer Medicine Information (CMI) about Somac Injection (pantoprazole sodium) intended for persons living in Australia.
  • Reaptan
    Drug - 2 Aug 2022
    Consumer Medicine Information (CMI) about Reaptan (Perindopril/amlodipine [pronounced per-in-do-pril/ am-load-i-peen]) intended for persons living in Australia.
  • Micardis
    Drug - 20 Jul 2022
    Consumer Medicine Information (CMI) about Micardis (telmisartan) intended for persons living in Australia.
  • Flagyl
    Drug - 29 Mar 2022
    Consumer Medicine Information (CMI) about Flagyl intended for persons living in Australia.
  • Colese
    Drug - 16 Feb 2022
    Consumer Medicine Information (CMI) about Colese intended for persons living in Australia.
  • Colofac
    Drug - 11 Feb 2022
    Consumer Medicine Information (CMI) about Colofac intended for persons living in Australia.
  • Mabcampath
    Drug - 10 Jan 2022
    Consumer Medicine Information (CMI) about Mabcampath intended for persons living in Australia.
  • Lomotil
    Drug - 1 Dec 2021
    Consumer Medicine Information (CMI) about Lomotil intended for persons living in Australia.
  • Lofenoxal
    Drug - 1 Dec 2021
    Consumer Medicine Information (CMI) about Lofenoxal intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback